You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 25, 2024

CLINICAL TRIALS PROFILE FOR AZTREONAM

✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for aztreonam

Subscribe to access the full database, or Try a Trial
Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00104520 ↗	Safety and Efficacy Study of Aztreonam for Inhalation Solution (AZLI) in Cystic Fibrosis Patients With P. Aeruginosa	Completed	Gilead Sciences	Phase 3	2005-02-01	The purpose of this study was to evaluate the safety and efficacy of aztreonam for inhalation solution (AZLI) in patients with cystic fibrosis (CF) and lung infection due to Pseudomonas aeruginosa (PA).
NCT00112359 ↗	International Safety and Efficacy Study of Aztreonam for Inhalation Solution (AZLI) in Cystic Fibrosis Patients With P. Aeruginosa	Completed	Gilead Sciences	Phase 3	2005-05-01	The purpose of this study was to evaluate the safety and efficacy of a 28-day course of aztreonam for inhalation solution (AZLI) in patients with cystic fibrosis (CF) and lung infection due to Pseudomonas aeruginosa (PA).
NCT00128492 ↗	Safety and Efficacy Study of Aztreonam for Inhalation Solution (AZLI) in Cystic Fibrosis (CF) Patients With Pseudomonas Aeruginosa (PA)	Completed	Gilead Sciences	Phase 3	2005-08-01	The purpose of this study was to evaluate the safety and efficacy of multiple courses of AZLI in patients with cystic fibrosis (CF) and lung infection due to Pseudomonas aeruginosa (PA).
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary

Clinical Trial Conditions for aztreonam

Condition Name

Chart
Table

Condition Name for aztreonam
Intervention	Trials
Cystic Fibrosis	19
Pseudomonas Aeruginosa	4
Infection	3
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for aztreonam
Intervention	Trials
Infections	29
Communicable Diseases	26
Infection	25
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for aztreonam

Trials by Country

Map
Table

Trials by Country for aztreonam
Location	Trials
United States	440
Australia	23
Spain	22
India	22
China	19
This preview shows a limited data set Subscribe for full access, or try a Trial

Trials by US State

Map
Table

Trials by US State for aztreonam
Location	Trials
California	25
Florida	23
Texas	22
Illinois	20
Ohio	19
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for aztreonam

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for aztreonam
Clinical Trial Phase	Trials
Phase 4	6
Phase 3	26
Phase 2/Phase 3	2
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for aztreonam
Clinical Trial Phase	Trials
Completed	43
Terminated	6
Recruiting	5
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for aztreonam

Sponsor Name

Chart
Table

Sponsor Name for aztreonam
Sponsor	Trials
Gilead Sciences	20
Pfizer	9
Forest Laboratories	5
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for aztreonam
Sponsor	Trials
Industry	62
Other	35
U.S. Fed	2
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.